KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Apr 25, 2024 $143.00 $145.77 $141.98 $143.71 476 835
Apr 24, 2024 $146.60 $147.49 $143.52 $143.80 367 635
Apr 23, 2024 $147.35 $150.27 $145.61 $146.07 532 485
Apr 22, 2024 $145.21 $147.86 $143.69 $145.79 393 642
Apr 19, 2024 $144.72 $146.92 $143.51 $144.41 639 358
Apr 18, 2024 $145.00 $146.45 $144.50 $145.16 390 153
Apr 17, 2024 $146.70 $147.49 $145.19 $145.32 474 926
Apr 16, 2024 $146.37 $148.44 $146.01 $146.72 347 421
Apr 15, 2024 $148.62 $150.37 $146.73 $147.70 441 540
Apr 12, 2024 $151.80 $151.80 $148.28 $148.50 409 245
Apr 11, 2024 $154.02 $154.02 $149.93 $152.09 463 215
Apr 10, 2024 $154.89 $154.89 $151.91 $152.41 530 228
Apr 09, 2024 $157.26 $159.34 $154.89 $155.90 582 390
Apr 08, 2024 $154.63 $157.96 $153.25 $156.04 726 692
Apr 05, 2024 $150.15 $154.00 $149.41 $153.56 349 035
Apr 04, 2024 $151.00 $154.34 $150.81 $151.48 526 033
Apr 03, 2024 $150.19 $151.27 $149.25 $150.83 305 634
Apr 02, 2024 $151.89 $152.27 $150.67 $151.04 442 271
Apr 01, 2024 $148.57 $154.20 $147.58 $153.33 501 749
Mar 28, 2024 $154.48 $154.50 $149.32 $149.45 554 941
Mar 27, 2024 $152.83 $155.28 $150.40 $154.39 441 586
Mar 26, 2024 $152.51 $153.43 $150.81 $151.97 519 649
Mar 25, 2024 $147.15 $152.63 $147.13 $152.07 753 039
Mar 22, 2024 $146.65 $147.10 $143.66 $146.51 813 207
Mar 21, 2024 $149.70 $150.68 $145.41 $146.62 593 836
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT